Dr. Pandit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6500 N Mopac Expy
Ste 200
Austin, TX 78731Phone+1 512-458-8400Fax+1 512-458-8593
Education & Training
- Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2016
- University of Texas Medical Branch HospitalsResidency, Internal Medicine, 2011 - 2014
- University of Arizona College of MedicineClass of 2011
Certifications & Licensure
- GA State Medical License 2024 - 2026
- IL State Medical License 2024 - 2026
- TN State Medical License 2024 - 2026
- TX State Medical License 2014 - 2026
- IN State Medical License 2024 - 2025
- AL State Medical License 2024 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- American Board of Obesity Medicine Obesity Medicine
Publications & Presentations
PubMed
- Beneficial Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Use With Control-IQ Technology in Type 2 Diabetes.Roy W Beck, Carol J Levy, Yogish C Kudva, Keta Pandit, Thomas Blevins
Clinical Diabetes. 2024-01-01 - 6 citationsBeneficial Effects of Control-IQ Automated Insulin Delivery in Basal-Bolus and Basal-Only Insulin Users With Type 2 Diabetes.Carol J Levy, Dan Raghinaru, Yogish C Kudva, Keta Pandit, Thomas Blevins
Clinical Diabetes. 2024-01-01
Press Mentions
- Weight Loss: Increased Protein Intake May Prevent Weight Regain After a DietDecember 13th, 2022
- The #1 Best Workout for People with Type 2 Diabetes, According to an EndocrinologistAugust 18th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: